Thursday, April 12, 2018
BRIEF-Vascepa Showed Fall In Atherogenic Lipid, Inflammatory Markers In Statin Treated Patients With Reduced Kidney Function
* VASCEPA SHOWED FALL IN ATHEROGENIC LIPID, INFLAMMATORY MARKERS IN STATIN-TREATED PATIENTS WITH REDUCED KIDNEY FUNCTION, PERSISTENT HIGH TRIGLYCERIDES Source text for Eikon: Further company coverage:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment